NIH Launches Trial for Potential Enterovirus D68 Treatment
The NIH is conducting a clinical trial to assess the safety and optimal dosage of an investigational monoclonal antibody developed from blood of recovering patients.
The NIH is conducting a clinical trial to assess the safety and optimal dosage of an investigational monoclonal antibody developed from blood of recovering patients.
The once-rare type of enterovirus has spread coast to coast to 22 states, up from 6 just a week ago, according to the CDC.